Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2011
Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expressionXiaoli Zhang, Amy S Farrell, Colin J Daniel, et al.
Molecular and Cellular Biology|May 30, 2013
Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesisAmy S Farrell, Carl Pelz, Xiaoyan Wang, et al.
Cancer Research Communications|November 24, 2025
MicroCT Enables Simultaneous Longitudinal Tracking of Murine Pancreatic Cancer Progression and CachexiaKatherine R Pelz, Philip Jimenez, Colin J Daniel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2014
Targeting c-MYC by antagonizing PP2A inhibitors in breast cancerMahnaz Janghorban, Amy S Farrell, Brittany L Allen-Petersen, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
MicroCT enables simultaneous longitudinal tracking of murine pancreatic cancer progression and cachexiaKatherine R Pelz, Philip Jimenez, Colin J Daniel, et al.
Genes & Development|October 28, 2018
Post-translational modification localizes MYC to the nuclear pore basket to regulate a subset of target genes involved in cellular responses to environmental signalsYulong Su, Carl Pelz, Tao Huang, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
MYC Serine 62 phosphorylation promotes its binding to DNA double strand breaks to facilitate repair and cell survival under genotoxic stressGabriel M Cohn, Colin J Daniel, Jennifer R Eng, et al.
Molecular Cancer Research : MCR|March 27, 2014
Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancerAmy S Farrell, Brittany Allen-Petersen, Colin J Daniel, et al.
Molecular Cancer Research : MCR|April 5, 2022
T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62Colin J Daniel, Carl Pelz, Xiaoyan Wang, et al.
The Journal of Clinical Investigation|November 26, 2019
Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneityTyler Risom, Xiaoyan Wang, Juan Liang, et al.
Pageof 4